Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
xeraya@xeraya.com
+603 2381 8700
Submit a Proposal
proposal@xeraya.com
Back

News & Events

Latest news and events related to our activities and our portfolio partners.
  • Xeraya Admin
  • Posted by Xeraya Admin
February 29, 2024
5 min read

Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System

  • Xeraya Admin
  • Posted by Xeraya Admin
February 29, 2024
5 min read

Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections

  • Xeraya Admin
  • Posted by Xeraya Admin
January 4, 2024
6 min read

GreenLight Biosciences Announces EPA Registration of Calantha

  • Xeraya Admin
  • Posted by Xeraya Admin
December 20, 2023
11 min read

U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)

  • Xeraya Admin
  • Posted by Xeraya Admin
November 27, 2023
4 min read

P2 Science Announces Appointment of Oihana Elizalde as CEO

  • Xeraya Admin
  • Posted by Xeraya Admin
November 8, 2023
7 min read

Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring

  • Xeraya Admin
  • Posted by Xeraya Admin
October 4, 2023
2 min read

RNAi pesticide moves closer to US approval

  • Xeraya Admin
  • Posted by Xeraya Admin
September 27, 2023
3 min read

InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO

  • Xeraya Admin
  • Posted by Xeraya Admin
August 31, 2023
6 min read

Foghorn Therapeutics Announces First Patient Dosed in Phase 1 Combination Study of FHD-286 for Relapsed and/or Refractory AML

  • Xeraya Admin
  • Posted by Xeraya Admin
June 27, 2023
4 min read

Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections

  • Xeraya Admin
  • Posted by Xeraya Admin
June 27, 2023
5 min read

Test Based on Glycoproteomic Profiles Shows High Sensitivity for Advanced Adenomas

  • Xeraya Admin
  • Posted by Xeraya Admin
May 8, 2023
5 min read

InterVenn Demonstrates Power of Its GlycoVision Platform In Advanced Adenoma and Colorectal Cancer

  • Xeraya Admin
  • Posted by Xeraya Admin
March 7, 2023
7 min read

GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day

  • Xeraya Admin
  • Posted by Xeraya Admin
January 9, 2023
9 min read

Foghorn Therapeutics Highlights Recent Clinical and Research Progress and Provides Strategic Objectives for 2023

  • Xeraya Admin
  • Posted by Xeraya Admin
January 5, 2023
7 min read

InterVenn Biosciences Enters Next Stage with Senior Management Team Updates Focused on Commercialization

  • Xeraya Admin
  • Posted by Xeraya Admin
December 9, 2022
1 min read

Xeraya Capital's Annual Dinner 2022

  • Xeraya Admin
  • Posted by Xeraya Admin
December 8, 2022
1 min read

MVCA Awards 2022

  • Xeraya Admin
  • Posted by Xeraya Admin
December 6, 2022
3 min read

Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter

  • Xeraya Admin
  • Posted by Xeraya Admin
November 22, 2022
3 min read

Merck to buy Xeraya-backed Imago BioSciences for $1.35b

  • Xeraya Admin
  • Posted by Xeraya Admin
November 3, 2022
3 min read

Acutus Medical achieves $20M milestone in Medtronic deal

  • Xeraya Admin
  • Posted by Xeraya Admin
October 19, 2022
1 min read

SIDC's Business Foresight Forum 2022 Highlights

  • Xeraya Admin
  • Posted by Xeraya Admin
October 5, 2022
6 min read

Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA: Cefepime/ Enmetazobactam Met Criteria for Superiority

  • Xeraya Admin
  • Posted by Xeraya Admin
October 5, 2022
6 min read

Nobel Prize goes to click chemists who discovered how to snap molecules together 'like Lego'

  • Xeraya Admin
  • Posted by Xeraya Admin
October 4, 2022
5 min read

InterVenn Biosciences Expands Board of Directors with Dr. Jason Myers and Carol Berry to Support Next Phase of Growth